Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
Authors
Keywords
-
Journal
BLOOD
Volume 135, Issue 25, Pages 2320-2322
Publisher
American Society of Hematology
Online
2020-06-18
DOI
10.1182/blood.2020006582
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study
- (2020) Chandy C. John et al. BLOOD
- Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
- (2020) Michael R. DeBaun BLOOD
- American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults
- (2020) M. R. DeBaun et al. Blood Advances
- Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia
- (2019) Melanie E. Fields et al. BLOOD
- Robust Clinical and Laboratory Response to Hydroxyurea Using Pharmacokinetically Guided Dosing for Young Children with Sickle Cell Anemia
- (2019) Patrick T. McGann et al. AMERICAN JOURNAL OF HEMATOLOGY
- RHgenotype matching for transfusion support in sickle cell disease
- (2018) Stella T. Chou et al. BLOOD
- Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities
- (2016) F. Bernaudin et al. BLOOD
- Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia
- (2016) Kerri A. Nottage et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
- (2016) Russell E Ware et al. LANCET
- Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia
- (2016) Djamila Labib Ghafuri et al. PEDIATRIC BLOOD & CANCER
- Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial
- (2015) Jane S. Hankins et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort
- (2015) IkeOluwa Lagunju et al. PEDIATRIC BLOOD & CANCER
- Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)
- (2012) R. E. Ware et al. BLOOD
- Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia
- (2012) Valentine Brousse et al. BRITISH JOURNAL OF HAEMATOLOGY
- Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease
- (2010) M. L. Hulbert et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now